Home/Filings/4/0001104659-19-058504
4//SEC Filing

5AM Opportunities I (GP), LLC 4

Accession 0001104659-19-058504

CIK 0001759138other

Filed

Oct 30, 8:00 PM ET

Accepted

Oct 31, 6:03 PM ET

Size

22.2 KB

Accession

0001104659-19-058504

Insider Transaction Report

Form 4
Period: 2019-10-29
Transactions
  • Conversion

    Common Stock

    2019-10-29+3,214,7213,214,721 total(indirect: See footnotes)
  • Conversion

    Series A Preferred Stock

    2019-10-293,146,5510 total(indirect: See footnotes)
    Common Stock (2,097,700 underlying)
  • Purchase

    Common Stock

    2019-10-29$11.00/sh+454,545$4,999,995454,545 total(indirect: See footnotes)
  • Conversion

    Series B Preferred Stock

    2019-10-291,675,5320 total(indirect: See footnotes)
    Common Stock (1,117,021 underlying)
Transactions
  • Conversion

    Common Stock

    2019-10-29+3,214,7213,214,721 total(indirect: See footnotes)
  • Conversion

    Series A Preferred Stock

    2019-10-293,146,5510 total(indirect: See footnotes)
    Common Stock (2,097,700 underlying)
  • Purchase

    Common Stock

    2019-10-29$11.00/sh+454,545$4,999,995454,545 total(indirect: See footnotes)
  • Conversion

    Series B Preferred Stock

    2019-10-291,675,5320 total(indirect: See footnotes)
    Common Stock (1,117,021 underlying)
Transactions
  • Purchase

    Common Stock

    2019-10-29$11.00/sh+454,545$4,999,995454,545 total(indirect: See footnotes)
  • Conversion

    Series B Preferred Stock

    2019-10-291,675,5320 total(indirect: See footnotes)
    Common Stock (1,117,021 underlying)
  • Conversion

    Common Stock

    2019-10-29+3,214,7213,214,721 total(indirect: See footnotes)
  • Conversion

    Series A Preferred Stock

    2019-10-293,146,5510 total(indirect: See footnotes)
    Common Stock (2,097,700 underlying)
PARMAR KUSH
10% Owner
Transactions
  • Purchase

    Common Stock

    2019-10-29$11.00/sh+454,545$4,999,995454,545 total(indirect: See footnotes)
  • Conversion

    Series B Preferred Stock

    2019-10-291,675,5320 total(indirect: See footnotes)
    Common Stock (1,117,021 underlying)
  • Conversion

    Common Stock

    2019-10-29+3,214,7213,214,721 total(indirect: See footnotes)
  • Conversion

    Series A Preferred Stock

    2019-10-293,146,5510 total(indirect: See footnotes)
    Common Stock (2,097,700 underlying)
Transactions
  • Conversion

    Common Stock

    2019-10-29+3,214,7213,214,721 total(indirect: See footnotes)
  • Conversion

    Series A Preferred Stock

    2019-10-293,146,5510 total(indirect: See footnotes)
    Common Stock (2,097,700 underlying)
  • Purchase

    Common Stock

    2019-10-29$11.00/sh+454,545$4,999,995454,545 total(indirect: See footnotes)
  • Conversion

    Series B Preferred Stock

    2019-10-291,675,5320 total(indirect: See footnotes)
    Common Stock (1,117,021 underlying)
Transactions
  • Purchase

    Common Stock

    2019-10-29$11.00/sh+454,545$4,999,995454,545 total(indirect: See footnotes)
  • Conversion

    Series B Preferred Stock

    2019-10-291,675,5320 total(indirect: See footnotes)
    Common Stock (1,117,021 underlying)
  • Conversion

    Common Stock

    2019-10-29+3,214,7213,214,721 total(indirect: See footnotes)
  • Conversion

    Series A Preferred Stock

    2019-10-293,146,5510 total(indirect: See footnotes)
    Common Stock (2,097,700 underlying)
Transactions
  • Conversion

    Common Stock

    2019-10-29+3,214,7213,214,721 total(indirect: See footnotes)
  • Conversion

    Series B Preferred Stock

    2019-10-291,675,5320 total(indirect: See footnotes)
    Common Stock (1,117,021 underlying)
  • Conversion

    Series A Preferred Stock

    2019-10-293,146,5510 total(indirect: See footnotes)
    Common Stock (2,097,700 underlying)
  • Purchase

    Common Stock

    2019-10-29$11.00/sh+454,545$4,999,995454,545 total(indirect: See footnotes)
Footnotes (5)
  • [F1]These shares of Series A Preferred Stock and Series B Preferred Stock (collectively, "Preferred Stock") automatically converted into shares of the Issuer's Voting Common Stock ("Common Stock"), on a 1-for-1.5 basis, immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date.
  • [F2]Shares are held directly by 5AM Ventures V, L.P. ("5AM V").
  • [F3]5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Dr. Parmar, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Preferred Stock held directly by 5AM V, except to the extent of its or his pecuniary interest therein.
  • [F4]Shares are held directly by 5AM Opportunities I, L.P. ("Opportunities").
  • [F5]5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of the shares of Common Stock held directly by Opportunities, except to the extent of its or his pecuniary interest therein.

Documents

1 file

Issuer

Cabaletta Bio, Inc.

CIK 0001759138

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001790778

Filing Metadata

Form type
4
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 6:03 PM ET
Size
22.2 KB